Cidara Therapeutics Receives $42,000,000 Series B Round

  • Feed Type
  • Date
  • Company Name
    Cidara Therapeutics
  • Mailing Address
    6310 Nancy Ridge Drive San Diego, CA 92121 USA
  • Company Description
    Our vision is to apply the versatile Cloudbreak small molecule immunotherapy platform to treat patients with compromised immune systems across multiple therapeutic areas.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the financing will enable us to accelerate the development of our echinocandin antifungal programs, biafungin and topifungin, as well as our immunotherapy platform, Cloudbreak, which, we believe, may represent a fundamentally new approach to the treatment of infectious diseases.
  • M&A Terms
  • Venture Investor

Trending on Xconomy